Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2970323509', 'doi': 'https://doi.org/10.1016/j.clml.2019.07.345', 'title': 'First Experience of Using 5-Azacytidine in Uzbekistan', 'display_name': 'First Experience of Using 5-Azacytidine in Uzbekistan', 'publication_year': 2019, 'publication_date': '2019-09-01', 'ids': {'openalex': 'https://openalex.org/W2970323509', 'doi': 'https://doi.org/10.1016/j.clml.2019.07.345', 'mag': '2970323509'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.clml.2019.07.345', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S186546955', 'display_name': 'Clinical Lymphoma Myeloma & Leukemia', 'issn_l': '2152-2669', 'issn': ['2152-2669', '2152-2650'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5064205375', 'display_name': 'Nigora Baymatova', 'orcid': None}, 'institutions': [], 'countries': ['UZ'], 'is_corresponding': False, 'raw_author_name': 'Nigora Baymatova', 'raw_affiliation_strings': ['Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan'], 'affiliations': [{'raw_affiliation_string': 'Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5083718742', 'display_name': 'Zulkhumor Yunusova', 'orcid': None}, 'institutions': [], 'countries': ['UZ'], 'is_corresponding': False, 'raw_author_name': 'Zulkhumor Yunusova', 'raw_affiliation_strings': ['Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan'], 'affiliations': [{'raw_affiliation_string': 'Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan', 'institution_ids': []}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3670, 'currency': 'USD', 'value_usd': 3670, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 62}, 'biblio': {'volume': '19', 'issue': None, 'first_page': 'S342', 'last_page': 'S342'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 0.8497, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 0.8497, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Efficacy and Resistance in CML Treatment', 'score': 0.829, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11440', 'display_name': 'Click Chemistry in Chemical Biology and Drug Development', 'score': 0.8245, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/treatment-discontinuation', 'display_name': 'Treatment Discontinuation', 'score': 0.450482}], 'concepts': [{'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.31350106}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.clml.2019.07.345', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S186546955', 'display_name': 'Clinical Lymphoma Myeloma & Leukemia', 'issn_l': '2152-2669', 'issn': ['2152-2669', '2152-2650'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.66, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2899084033', 'https://openalex.org/W2748952813', 'https://openalex.org/W2530322880', 'https://openalex.org/W2390279801', 'https://openalex.org/W2382290278', 'https://openalex.org/W2376932109', 'https://openalex.org/W2358668433', 'https://openalex.org/W2350741829', 'https://openalex.org/W2130043461', 'https://openalex.org/W2001405890'], 'abstract_inverted_index': {'Study': [0], 'of': [1, 3], 'efficacy': [2], '5-azacytidine': [4], 'treatment': [5], 'in': [6, 16], 'myelodysplastic': [7], 'syndrome': [8], '(MDS)': [9], 'and': [10], 'acute': [11], 'myeloid': [12], 'leukemia': [13], '(AML)': [14], 'patients': [15], 'Uzbekistan.': [17]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2970323509', 'counts_by_year': [], 'updated_date': '2024-09-11T18:59:35.237997', 'created_date': '2019-09-05'}